European Randomized Study Of Screening For Prostate Cancer (erspc)

ROTTERDAM, The Netherlands, December 8 - The effectiveness of PSA (prostate-specific antigen) screening on reducing prostate cancer mortality has been given a boost with new data from the European Randomized Study of Screening for Prostate Cancer (ERSPC).